CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
about
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disordersInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingγ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF AβBiomarkers for cognitive impairment and dementia in elderly people.Magnetic resonance spectroscopy in the diagnosis of dementia with Lewy bodies.Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.Delirium and dementia with Lewy bodies: distinct diagnoses or part of the same spectrum?Cerebrospinal fluid biomarkers of Alzheimer's disease.Biomarkers for cognitive impairment in Parkinson disease.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementiaThe spectrum of cognitive impairment in Lewy body diseasesDevelopment of a novel cellular model of Alzheimer's disease utilizing neurosphere cultures derived from B6C3-Tg(APPswe,PSEN1dE9)85Dbo/J embryonic mouse brainCombined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia.CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.Cerebrospinal fluid biomarkers for dementia with lewy bodies.Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammationBiomarkers in Alzheimer's disease.Beta-amyloid peptide variants in brains and cerebrospinal fluid from amyloid precursor protein (APP) transgenic mice: comparison with human Alzheimer amyloid.Magneto-immunocapture with on-bead fluorescent labeling of amyloid-β peptides: towards a microfluidized-bed-based operation.Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.Olfactory impairment predicts cognitive decline in early Parkinson's disease.Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.Neurochemical biomarkers in Alzheimer's disease and related disorders.Nanofluidic biosensing for beta-amyloid detection using surface enhanced Raman spectroscopyCurrent state and future directions of neurochemical biomarkers for Alzheimer's disease.Distinguishing Lewy body dementias from Alzheimer's disease.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.Measuring target effect of proposed disease-modifying therapies in Alzheimer's diseaseLongitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a reviewCritical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention.Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.Problems associated with fluid biomarkers for Parkinson's disease.Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.Biomarkers in dementia with Lewy bodies: a review.CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.Interaction between pathogenic proteins in neurodegenerative disorders.
P2860
Q26850298-450DD2A4-A74D-4C3A-B561-5E72462DB386Q28076999-42BAC2B0-D46B-4783-B792-C9D9226974BEQ28687678-2AF8E4DA-6EC2-4C54-90FA-AE2FACD44B50Q30370745-D9987EE1-D8F4-49E8-B912-FC454F60112BQ30841801-E87768DF-23D0-4796-A6A4-0196A82ADD2FQ31146512-23307F04-2F48-4677-A628-0B22E63A3EAAQ33164331-D83976DC-6EAB-426C-AACB-77A4ED940EE9Q33757828-59C11FF5-6391-4296-853D-1C22F1A5A7C0Q33896664-58783260-A5AC-444E-8A47-967FC1D23C7BQ33936708-3EFC4F1B-124D-42D1-89F3-91E28BB73C0AQ34019751-50653800-54FD-4489-89C2-4760DBF7C68AQ34063838-C9395B8A-AF29-439C-AF59-31118676E3D8Q34123736-FD1AC1B9-7163-4D1C-A65B-DC6DD36D49C8Q34140382-A4D9474B-7C92-4337-858F-18B5DAEDEE54Q34244772-E0287005-56E1-49DB-B718-F831B64F7DD3Q34248241-1D97D712-428F-4AED-B7EC-A9F241EA7485Q34315258-63AFB6F6-06C8-48B5-9500-697865D43ABFQ34394932-29AB939F-1F86-411D-A402-F317F1F42825Q35113795-7EA185B4-8616-4365-B8F2-19324B4845DAQ35311113-92037A95-9E51-4C8D-A1BC-08EBA5A13CCAQ35709581-84425307-EF73-44DC-959D-A1E5AD203B35Q35772659-B3178266-4B63-482F-8241-5A6C82F61979Q35938758-3E59E40F-96E0-4867-8914-3CDD5664C6ACQ36351543-6D73A3BA-4506-457C-9AA4-7D7FFE0B1826Q36366891-C26C559A-506F-4759-AB60-6732E0C4E344Q36983997-6A7F5AF8-8370-4254-BD01-CB3F4450D3EEQ36985933-B84CCD30-C71D-459A-800E-F7D6104ADECBQ36998833-0DECE2C9-989E-4F5E-9A44-BF5B51C8413CQ37118083-810F7F17-222B-4350-91FB-E804AC37F163Q37157835-BD1FB9F2-8F9D-4DEB-85F4-EE19AC79767EQ37215837-19B3F87E-96D2-43FD-A094-028EB6E1E9A7Q37345484-CBD08857-BEA4-4144-8224-C16060807983Q37418238-47B60C7C-702A-4230-A075-AF5ABDA5D776Q37438267-0A6187AF-20F5-44A5-A2AF-739B5B485894Q37693146-980C429F-5586-4105-87B2-E88C0CF01CD1Q37800100-3E0B29CC-5DB6-4326-8216-595ED65B5F35Q37800101-8AD51B9E-E01D-4507-99B1-DD8026F7108FQ37896548-AA961D92-2683-41AD-AEAE-8FAB150CDC37Q37953330-52939F2B-5CC2-43C9-9490-D4F7B873F269Q37969262-DF8D6F6D-3F60-4368-868A-FE2935835A92
P2860
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@ast
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@en
type
label
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@ast
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@en
prefLabel
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@ast
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@en
P2093
P2860
P50
P921
P356
P1433
P1476
CSF amyloid-beta-peptides in A ...... d Parkinson's disease dementia
@en
P2093
Alexandr Smirnov
Eckart Rüther
Hans-Wolfgang Klafki
Hermann Esselmann
Katrin Sparbier
Lukas Cepek
Markus Otto
Mirko Bibl
Piotr Lewczuk
P2860
P304
P356
10.1093/BRAIN/AWL063
P407
P577
2006-04-06T00:00:00Z